Sign in

CIK 0001604191

  • Non-accelerated filer
  • Smaller reporting company

GridAI Technologies Corp.

Sign in to watch
Ticker
GRDX
Exchange
Nasdaq
Industry
Electric & Other Services Combined
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464993860
Phone
+1 561-589-7020
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL
Former names
Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
  1. 4 Grant or award Director acquired 30,000 shares (grant or award)
  2. 4 Grant or award Director acquired 30,000 shares (grant or award)
  3. 4 Grant or award Director acquired 7,500 shares (grant or award)
  4. 4 Grant or award Director acquired 7,500 shares (grant or award)
  5. 4 Grant or award Director acquired 7,500 shares (grant or award)
  6. 4 Grant or award Director acquired 7,500 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy 10% owner bought 139,545 shares at an average $1.35 ($188,472)
  9. 4 Open-market buy PRESIDENT AND CEO bought 38,583 shares at $1.30 ($49,969)
  10. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 20,000 shares at $1.31 ($26,214)
  11. 4 Grant or award Director acquired 7,500 shares (grant or award)
  12. 4 Grant or award Director acquired 7,500 shares (grant or award)
  13. 4 Open-market buy Director bought 9,000 shares at $1.41 ($12,690)
  14. 4 Grant or award Director acquired 7,500 shares (grant or award)
  15. 4 Grant or award Director acquired 7,500 shares (grant or award)
  16. 4 Grant or award Director acquired 7,500 shares (grant or award)
  17. 4 Grant or award Director acquired 7,500 shares (grant or award)
  18. 4 Grant or award Director acquired 7,500 shares (grant or award)
  19. 4 Grant or award Director acquired 7,500 shares (grant or award)
  20. 4/A Option exercise Director acquired 36,000 shares (option exercise)

Page 7 of 10 · 181 filings